Nachrichten zur Pfizer Inc. Aktie

Stocks making the biggest moves midday: Spotify, General Motors, Royal Caribbean, Pfizer and more

These are the stocks posting the largest moves in midday trading.…

Stocks making the biggest moves midday: Spotify, Regeneron, Hims & Hers, Pfizer and more

These are the stocks posting the largest moves in midday trading.…

Pfizer Aktie: Einsparungen zeigen Wirkung

Wien (www.aktiencheck.de) - Pfizer-Aktienanalyse der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), nimmt in einer…

Pfizer Q1 Earnings Beat Estimates, Several Headwinds Hurt Sales

PFE beats first-quarter estimates for earnings but misses the same for sales. It maintains 2025 guidance.…

Pfizer Aktie: Kaufempfehlung trotz Risiken - HSBC bleibt langfristig optimistisch

London (www.aktiencheck.de) - Pfizer-Aktienanalyse von HSBC: Aktuelle Bewertung HSBC hat das Kursziel für Pfizer Inc. (ISIN: US7170811035, WKN: 852009, Ticker-Symbol: PFE, NYSE-Symbol:…

Pfizer expands cost cuts, tops quarterly profit estimates even as sales fall

Pfizer maintained its 2025 guidance but noted it does not include any impact of tariffs or trade policy, "which we…

UBS belässt Pfizer auf Neutral - Ziel 24 Dollar

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Pfizer nach Zahlen zum ersten Quartal auf "Neutral"…

If Youd Invested $10,000 in Pfizer Stock 10 Years Ago, Heres How Much Youd Have Today

Things were going great, right until the point when they werent.…

Pfizer: Prognose steht – 7,5 Prozent Dividendenrendite

Der amerikanische Pharma-Konzern Pfizer hat am Dienstag vor der US-Börseneröffnung die Zahlen für das erste Quartal 2025 vorgelegt. Diese sind…

Pfizer: Prognose steht – 7,5 Prozent Dividendenrendite

Der amerikanische Pharma-Konzern Pfizer hat am Dienstag vor der US-Börseneröffnung die Zahlen für das erste Quartal 2025 vorgelegt. Diese sind…

Pfizer beats profit estimates on cost cuts, heart drug sales

U.S. drugmaker Pfizer reported first-quarter profit above Wall Street estimates on Tuesday, helped by cots cuts and better-than-expected sales of…

Pfizer shares rise on Q1 earnings beat, expands cost-cutting program

Pfizer Inc (NYSE:PFE, ETR:PFE) reported mixed results for the first quarter, including an earnings beat but revenue below expectations. Revenue…

Pfizer delivers mixed results for Q1, expands cost-cutting program

Pfizer Inc (NYSE:PFE, ETR:PFE) reported mixed results for the first quarter, including an earnings beat but revenue below expectations. Revenue…

Zacks.com featured highlights StoneCo, Carriage Services, Associated Banc-Corp and Pfizer

StoneCo, Carriage Services, Associated Banc-Corp and Pfizer have been highlighted in this Screen of The Week article.…

Stock Market Today: Dow, S&P 500, Nasdaq Futures Rising; Trump Tariff Hopes; Plug Power, Pfizer, GM, Tesla, More Movers

Dow, S&P 500, and Nasdaq 100 futures are rising in premarket trading ahead of an expected auto tariffs announcement by…

Dow Jones up and Nasdaq down as futures point to mixed session amidst earnings torrent

US stock market indexes are set for another mixed session on Tuesday, as a busy week for earnings continues, with numbers…

3 Dividend Stocks to Buy and Hold for the Next Decade

Many income investors would love to have a low-maintenance portfolio that doesnt require constant attention. Theyd prefer to buy great…

Down 36%, Is Moderna a Buy on the Dip?

In many ways, the pandemic is becoming a faded memory. With that, a major pandemic star -- biotech Moderna (NASDAQ:…

My 5 Top Stocks to Buy Right Now in This Highly Volatile Market

Getting dizzy from the stock markets gyrations? Join the club. The major market indexes are behaving like a frantic yo-yo,…

1 Stock to Buy, 1 Stock to Sell This Week: Meta Platforms, Pfizer

• Tariff headlines, ‘Mag 7’ earnings, U.S. jobs report, and PCE inflation data will be in focus this week.…

Pfizer: I Am Locking In A 7.5% Dividend Yield Before Earnings

…

Pfizer Aktie: Kursziel revidiert

Charlotte (www.aktiencheck.de) - Rating-Update: Die Analysten von BofA Securities stufen die Aktie von Pfizer Inc. (ISIN: US7170811035, WKN: 852009, Ticker-Symbol: PFE,…

Will Pfizers Non-COVID Drugs Drive Sales Again This Earnings Season?

Pfizers non-COVID drugs and contributions from new and newly acquired products are likely to have driven top-line growth in the…

5 All-Weather Dividend Stocks to Buy Right Now

Market uncertainty has become the defining characteristic of the 2025 investment landscape. Thanks to volatile trade policies, persistent inflation concerns,…

2 No-Brainer Stocks to Buy With Less Than $30

Having significant capital in the bank when investing in equities is helpful, but is by no means necessary. Even with…

Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know

In the closing of the recent trading day, Pfizer (PFE) stood at $22.36, denoting a -0.78% change from the preceding…

2 High-Yield Dividend Stocks to Buy for Passive Income

Passive income is essential in retirement, but building a dependable stream isnt easy. Fortunately, top-tier dividend stocks can do the…

Whats Next for Pfizer After the Company Pulls Its Weight Loss Drug?

The anti-obesity drug market has the potential to be massive, with multiple analysts projecting it may reach at least $100…

Whats Next for Pfizer After the Company Pulls Its Weight Loss Drug? @themotleyfool #stocks $PFE

…

Pfizer Stock Before Q1 Earnings Release: To Buy or Not to Buy?

PFEs non-COVID drugs and contributions from new and newly acquired products are likely to have driven top-line growth in the…

Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday

Vertex Pharmaceuticals (NASDAQ: VRTX) had a fine Tuesday on the stock exchange. The biotechs shares closed the day nearly 3%…

3 Ultra-High-Yield Dividend Stocks to Buy Right Now That Are Dirt Cheap

Every cloud has a silver lining. Sometimes, they have two. Thats the case with many stocks in the current market…

A Once-in-a-Decade Opportunity: 3 Magnificent Stocks Down Between 40% and 73% to Buy Right Now

The S&P 500 has dropped 10% or more nine times since 2010, not including the current sell-off. However, the index…

3 Magnificent Stocks to Buy That Are Near 52-Week Lows

Its been a tough start to 2025 for investors amid concerns regarding the strength of the U.S. economy and uncertainties…

Pfizer Abandons Its Leading Weight Loss Candidate. Should You Sell the Stock?

Although it isnt the largest therapeutic area in the pharmaceutical industry, the market for weight loss therapies has caught fire…

Huntingtons Disease Treatment Market to Hit $2.03 Billion by 2033, Driven by Cutting-Edge Therapies

Factors driving the market include rising disease prevalence, innovative therapies, and gene-based treatment breakthroughs. Key players like H Lundbeck and…

Pfizer (PFE) Laps the Stock Market: Heres Why

Pfizer (PFE) closed the most recent trading day at $22.15, moving +0.48% from the previous trading session.…

Vaccine Stocks Rise on Growing Threat of Bird Flu Infections

The Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE) to develop bird flu vaccines…

Pfizer: Risks Priced In, Buy The Exceptional Valuation And Yield

…

ANALYSE-FLASH: JPMorgan belässt Pfizer auf 'Neutral' - Ziel 30 Dollar

NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat die Einstufung für Pfizer mit einem…

ANALYSE-FLASH: JPMorgan belässt Pfizer auf 'Neutral' - Ziel 30 Dollar

NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat die Einstufung für Pfizer nach Zahlen…

Pfizer übertrifft Umsatzerwartung - Aktie gefragt

NEW YORK (dpa-AFX) - Der US-Pharmakonzern Pfizer hat nach einem überraschend starken Schlussquartal 2024 seinen…

Pfizer peilt für 2025 Umsatz auf Vorjahreshöhe an - Gewinnsteigerung möglich

NEW YORK (dpa-AFX) - Der US-Pharmakonzern Pfizer blickt verhalten auf das kommende Jahr. 2025 werde…

Prozess um von der Leyens SMS mit Pfizer geht in heiße Phase

LUXEMBURG (dpa-AFX) - Der Prozess um SMS zwischen EU-Kommissionspräsidentin Ursula von der Leyen und dem Chef…

Pfizer erhöht erneut Prognose - Aktie vorbörslich im Plus

NEW YORK (dpa-AFX) - Beim US-Pharmakonzern Pfizer geht es weiter aufwärts. Nach einem abermals unerwartet…

ANALYSE-FLASH: JPMorgan belässt Pfizer auf 'Neutral' - Ziel 30 Dollar

NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat die Einstufung für Pfizer mit einem…

Pfizer will bis Ende 2027 rund 1,5 Milliarden US-Dollar einsparen

NEW YORK (dpa-AFX) - Der US-Pharmakonzern Pfizer will bis Ende 2027 rund 1,5 Milliarden US-Dollar…

WDH/ANALYSE-FLASH: Jefferies belässt Pfizer auf 'Buy' - Ziel 32 Dollar

(Wiederholung vom Vorabend) NEW YORK (dpa-AFX Broker) - Das Analysehaus Jefferies hat die…

ANALYSE-FLASH: JPMorgan belässt Pfizer auf 'Neutral' - Ziel 30 Dollar

NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat die Einstufung für Pfizer nach Zahlen…

ANALYSE-FLASH: Jefferies senkt Ziel für Pfizer auf 32 Dollar - 'Buy'

NEW YORK (dpa-AFX Broker) - Das Analysehaus Jefferies hat das Kursziel für Pfizer nach Zielvorgaben…